A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: harsh (4), strict (49), acute (409)

Pertuzumab/Trastuzumab SC

Description
Chemotherapy Protocol BREAST CANCER Regimen Pertuzumab / Trastuzumab SC • Breast Cancer – Trastuzumab / Pertuzumab SC Indication • Trea
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/PertuzumabTrastuzumab-SC.pdf

Atezolizumab-Paclitaxel Albumin Bound

Description
Chemotherapy Protocol BREAST CANCER Atezolizumab-Paclitaxel Albumin Bound Regimen • Breast – Atezolizumab-Paclitaxel Albumin Bound Indication • A
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Atezolizumab-Paclitaxel-Albumin-Bound.pdf

Annual-report-2018-19

Description
ANNUAL REPORT AND ACCOUNTS 2018/19 incorporating the quality account 2018/19 Presented to Parliament pursuant to Schedule 7, paragraph 25
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/annual-report-2018-19.pdf

Ectropion - patient information

Description
This factsheet explains what ectropion is and how it is treated.
Url
/Media/UHS-website-2019/Patientinformation/Eyes/Ectropion-1909-PIL.pdf

Gepants for the prevention of episodic and chronic migraine - patient information

Description
This factsheet contains information about a preventative treatment for episodic and chronic migraine called gepants.
Url
/Media/UHS-website-2019/Patientinformation/Brain-and-spine/Gepants-for-the-prevention-of-episodic-and-chronic-migraine-3895-PIL.pdf

Selinexor Bortezomib Dexamethasone

Description
Chemotherapy Protocol Multiple Myeloma Selinexor with Bortezomib and Dexamethasone Regimen • SELINEXOR (PO) – BORTEZOMIB (SC) – DEXAMETHA
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/Selinexor-Bortezomib-Dexamethasone-Ver1.pdf

Atezolizumab (1875mg 21-days) SC

Description
Chemotherapy Protocol UROTHELIAL CANCER Atezolizumab SC (1875mg – 21 days) Regimen • Urothelial cancer – Atezolizumab monotherapy (1st or 2nd lin
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Bladdercancer/Atezolizumab-SC-1875mg-21-days.pdf

Diverticular disease and diverticulitis - patient information

Description
This factsheet explains what diverticular disease and diverticulitis are, what the symptoms are and how they can be treated.
Url
/Media/UHS-website-2019/Patientinformation/Endoscopy/Diverticular-disease-and-diverticulitis-989-PIL.pdf

Cannabinoid hyperemesis syndrome (CHS) - patient information

Description
This factsheet explains what cannabinoid hyperemesis syndrome is, the symptoms to look out for and how it is treated.
Url
/Media/UHS-website-2019/Patientinformation/Emergency-medicine/Cannabinoid-hyperemesis-syndrome-CHS-2506-PIL.pdf

Zanubrutinib Ver1

Description
Chemotherapy Protocol LYMPHOMA ZANUBRUTINIB Regimen • Lymphoma - Zanubrutinib Indication Zanubrutinib monotherapy for the treatme
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Zanubrutinib.pdf
71 to 80 of 726
Previous … 6 7 8 9 10 … Next